Articles related to VALVULAR HEART DISEASE (VHD)

A European Heart Journal debate revisits whether surgical aortic valve replacement should remain the preferred approach for patients with aortic stenosis and life expectancy beyond five years. Long-term durability and late procedural outcomes continue to shape the discussion.

Dr. Nidhi Madan discusses building a rural structural heart program at Bassett Medical Center, the health equity gaps keeping high-burden patients from reaching heart team evaluation, and why cardiac CT fluency has become a foundational competency for the modern structural interventionalist.

Patients with primary tricuspid regurgitation had longer survival than those with secondary or lead-associated TR in a 12,899-patient Mayo Clinic retrospective cohort.

Registry data shows that comorbidities not captured in traditional surgical risk scores, particularly atrial fibrillation and poor baseline functional status, significantly impact post-TAVR outcomes in low-risk patients.

DETECT AS trial showed electronic notifications increased AVR rates by 11% overall and 14% in symptomatic patients, while EARLY TAVR analyses confirmed superior outcomes with timely intervention versus surveillance, with biomarkers failing to predict optimal treatment timing.

The bRIGHT study demonstrates that T-TEER using the TriClip system can lead to sustained TR reduction and quality of life improvements in a diverse, real-world population with advanced tricuspid valve disease.